Skip to content
My WebMD Sign In, Sign Up
Orinase

Interactions

Selected Oral Antidiabetics/Selected Anticoagulants

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

When these two medications are taken together, your anticoagulant may cause your body to process the antidiabetic medicine more slowly.

What might happen:

The effects of your antidiabetic medicine may increase and cause low blood sugar.

What you should do about this interaction:

Contact your healthcare professionals (e.g. doctor or pharmacist) as soon as possible about taking these two medicines together. They may already be aware of this interaction and may be monitoring you for it. If your doctor prescribes these medicines together, it may be necessary to check your blood sugar levels more often.If you experience a sudden onset of cold sweat, dizziness, fatigue, shakiness, rapid heartbeat, nausea, vision changes, confusion, personality change, nervousness, hunger, or sweating, contact your doctor. Do not start, stop, or change the dosage of any medicine without checking with a healthcare professional first.

References:

1.Kristensen M, Hansen JM. Accumulation of chlorpropamide caused by dicoumarol. Acta Med Scand 1968 Jan-Feb;183(1-2):83-6.

2.Solomon HM, Schrogie JJ. Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects. Metabolism 1967 Nov; 16(11):1029-33.

3.Skovsted L, Kristensen M, Hansen M, Siersbaek-Nielsen K. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism. Acta Med Scand 1976;199(6):513-5.

4.Spruny OM, Wolf JW, Devins GS. Protracted tolbutamide-induced hypoglycemia. Arch Intern Med 1965 Jan;115:53-6.

5.Judis J. Displacement of sulfonylureas from human serum proteins by coumarin derivatives and cortical steroids. J Pharm Sci 1973 Feb; 62(2):232-7.

6.Kristensen M, Hansen JM. Potentiation of the tolbutamide effect by dicoumarol. Diabetes 1967 Apr;16(4):211-4.

7.Chaplin H Jr, Cassell M. Studies on the possible relationship of tolbutamide to dicumarol in anticoagulant therapy. Am J Med Sci 1958 Jun; 235:706-15.

8.Poucher RL, Vecchio TJ. Absence of tolbutamide effect on anticoagulant therapy. JAMA 1966 Sep 26;197(13):1069-70.

9.Jahnchen E, Meinertz T, Gilfrich HJ, Groth U. Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man. Eur J Clin Pharmacol 1976 Sep 30;10(5):349-56.

10.Petitpierre B, Perrin L, Rudhardt M, Herrera A, Fabre J. Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy. Int J Clin Pharmacol 1972 Jun;6(2):120-4.

11.Kolenda KD, Grille W, Johnsen K. Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out- patients (author's transl). Med Klin 1979 Dec 14;74(50):1914-22.

12.Heine P, Kewitz H, Wiegboldt KA. The influence of hypoglycaemic sulphonylureas on elimination and efficacy of phenprocoumon following a single oral dose in diabetic patients. Eur J Clin Pharmacol 1976;10:31-6.

13.Brown KF, Crooks MJ. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs. Biochem Pharmacol 1976 May 15;25(10):1175-8.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

More about Drugs and Medications

URAC: Accredited Health Web Site HONcode Seal AdChoices